• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在无痴呆症个体中,灰质网络特性与脑脊液磷酸化tau蛋白181水平及淀粉样蛋白状态呈现出不同的关联。

Gray matter network properties show distinct associations with CSF p-tau 181 levels and amyloid status in individuals without dementia.

作者信息

Luigi Lorenzini, Silvia Ingala, Viktor Wottschel, Wink Alle Meije, Mutsaerts Henk Jmm, Sven Haller, Kaj Blennow, O'Brien John T, Giovanni Frisoni B, Gael Chételat, Pierre Payoux, Pablo Martinez-Lage, Adam Waldman, Joanna Wardlaw, Craig Ritchie, Gispert Juan Domingo, Visser Pieter Jelle, Philip Scheltens, Frederik Barkhof, Tijms Betty M

机构信息

Dept. of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, Amsterdam Neuroscience, Amsterdam, the Netherlands.

Ghent Institute for Functional and Metabolic Imaging (GIfMI), Ghent University, Ghent, Belgium.

出版信息

Aging Brain. 2022 Oct 23;2:100054. doi: 10.1016/j.nbas.2022.100054. eCollection 2022.

DOI:10.1016/j.nbas.2022.100054
PMID:36908898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9997148/
Abstract

Gray matter networks are altered with amyloid accumulation in the earliest stage of AD, and are associated with decline throughout the AD spectrum. It remains unclear to what extent gray matter network abnormalities are associated with hyperphosphorylated-tau (p-tau). We studied the relationship of cerebrospinal fluid (CSF) p-tau181 with gray matter networks in non-demented participants from the European Prevention of Alzheimer's Dementia (EPAD) cohort, and studied dependencies on amyloid and cognitive status. Gray matter networks were extracted from baseline structural 3D T1w MRI. P-tau181 and abeta were measured with the Roche cobas Elecsys System. We studied the associations of CSF biomarkers levels with several network's graph properties. We further studied whether the relationships of p-tau 181 and network measures were dependent on amyloid status and cognitive stage (CDR). We repeated these analyses for network properties at a regional level, where we averaged local network values across cubes within each of 116 areas as defined by the automated anatomical labeling (AAL) atlas. Amyloid positivity was associated with higher network size and betweenness centrality, and lower gamma, clustering and small-world coefficients. Higher CSF p-tau 181 levels were related to lower betweenness centrality, path length and lambda coefficients (all p < 0.01). Three-way interactions between p-tau181, amyloid status and CDR were found for path length, lambda and clustering (all p < 0.05): Cognitively unimpaired amyloid-negative participants showed lower path length and lambda values with higher CSF p-tau181 levels. Amyloid-positive participants with impaired cognition demonstrated lower clustering coefficients in association to higher CSF p-tau181 levels. Our results suggest that alterations in gray matter network clustering coefficient is an early and specific event in AD.

摘要

在阿尔茨海默病(AD)的最早阶段,灰质网络会随着淀粉样蛋白的积累而发生改变,并与整个AD谱系中的衰退相关。目前尚不清楚灰质网络异常与过度磷酸化tau蛋白(p-tau)的关联程度。我们研究了来自欧洲预防阿尔茨海默病痴呆(EPAD)队列的非痴呆参与者脑脊液(CSF)中p-tau181与灰质网络的关系,并研究了其对淀粉样蛋白和认知状态的依赖性。从基线结构3D T1w MRI中提取灰质网络。使用罗氏cobas Elecsys系统测量p-tau181和β淀粉样蛋白。我们研究了脑脊液生物标志物水平与几个网络的图属性之间的关联。我们进一步研究了p-tau 181与网络测量值之间的关系是否依赖于淀粉样蛋白状态和认知阶段(CDR)。我们对区域水平的网络属性重复了这些分析,在该水平上,我们对由自动解剖标记(AAL)图谱定义的116个区域内每个立方体的局部网络值进行了平均。淀粉样蛋白阳性与更大的网络规模和中介中心性相关,而与更低的γ、聚类和小世界系数相关。更高的脑脊液p-tau 181水平与更低的中介中心性、路径长度和λ系数相关(所有p<0.01)。在路径长度、λ和聚类方面发现了p-tau181、淀粉样蛋白状态和CDR之间的三向相互作用(所有p<0.05):认知未受损的淀粉样蛋白阴性参与者在脑脊液p-tau181水平较高时表现出更低的路径长度和λ值。认知受损的淀粉样蛋白阳性参与者在脑脊液p-tau181水平较高时表现出更低的聚类系数。我们的结果表明,灰质网络聚类系数的改变是AD中的一个早期且特定的事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb9/9997148/1993273beeb3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb9/9997148/7fdc04cb2753/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb9/9997148/5bd2651b9a0f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb9/9997148/7efc9b173557/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb9/9997148/1993273beeb3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb9/9997148/7fdc04cb2753/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb9/9997148/5bd2651b9a0f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb9/9997148/7efc9b173557/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb9/9997148/1993273beeb3/gr4.jpg

相似文献

1
Gray matter network properties show distinct associations with CSF p-tau 181 levels and amyloid status in individuals without dementia.在无痴呆症个体中,灰质网络特性与脑脊液磷酸化tau蛋白181水平及淀粉样蛋白状态呈现出不同的关联。
Aging Brain. 2022 Oct 23;2:100054. doi: 10.1016/j.nbas.2022.100054. eCollection 2022.
2
Tau-related grey matter network breakdown across the Alzheimer's disease continuum.tau 相关灰质网络在阿尔茨海默病连续体中的崩溃。
Alzheimers Res Ther. 2021 Aug 13;13(1):138. doi: 10.1186/s13195-021-00876-7.
3
Gray matter network disruptions and amyloid beta in cognitively normal adults.认知正常成年人的灰质网络破坏与β淀粉样蛋白
Neurobiol Aging. 2016 Jan;37:154-160. doi: 10.1016/j.neurobiolaging.2015.10.015. Epub 2015 Oct 22.
4
Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging.使用基于弥散的神经炎症成像技术研究阿尔茨海默病中的脑白质神经炎症。
Neurology. 2024 Feb;102(4):e208013. doi: 10.1212/WNL.0000000000208013. Epub 2024 Feb 5.
5
Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults.在无淀粉样蛋白的老年人群中,年龄、血管疾病和阿尔茨海默病病理。
Alzheimers Res Ther. 2021 Oct 15;13(1):174. doi: 10.1186/s13195-021-00913-5.
6
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.血液磷酸化 tau 181 作为阿尔茨海默病的生物标志物:使用来自四个前瞻性队列的数据进行的诊断性能和预测模型研究。
Lancet Neurol. 2020 May;19(5):422-433. doi: 10.1016/S1474-4422(20)30071-5.
7
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.阿尔茨海默病谱中血液磷酸化 tau181 的时间进程。
Brain. 2021 Feb 12;144(1):325-339. doi: 10.1093/brain/awaa399.
8
CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals.脑脊液 tau368/总 tau 比值比 p-tau181 和 p-tau217 更能反映认知障碍个体的认知表现和新皮层 tau。
Alzheimers Res Ther. 2022 Dec 22;14(1):192. doi: 10.1186/s13195-022-01142-0.
9
Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum.小胶质细胞激活、tau病理改变及神经退行性变生物标志物可预测阿尔茨海默病连续体中的纵向认知衰退。
Front Aging Neurosci. 2022 Jun 30;14:848180. doi: 10.3389/fnagi.2022.848180. eCollection 2022.
10
Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.区域脑白质高信号与认知正常和轻度认知障碍老年人的阿尔茨海默病生物标志物。
J Alzheimers Dis. 2023;92(1):323-339. doi: 10.3233/JAD-220846.

引用本文的文献

1
Brain MRI signatures across sex and CSF Alzheimer's disease biomarkers.跨性别脑磁共振成像特征与脑脊液阿尔茨海默病生物标志物
Brain Commun. 2025 May 30;7(3):fcaf210. doi: 10.1093/braincomms/fcaf210. eCollection 2025.
2
Detection of cerebrospinal fluid biomarkers changes of Alzheimer's disease using a cognitive stress test in persons with subjective cognitive decline and mild cognitive impairment.使用认知应激测试检测主观认知下降和轻度认知障碍患者阿尔茨海默病脑脊液生物标志物的变化。
Front Psychol. 2024 Jun 26;15:1373541. doi: 10.3389/fpsyg.2024.1373541. eCollection 2024.

本文引用的文献

1
CAT: a computational anatomy toolbox for the analysis of structural MRI data.CAT:用于分析结构磁共振成像数据的计算解剖工具箱。
Gigascience. 2024 Jan 2;13. doi: 10.1093/gigascience/giae049.
2
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease.脑脊液 tau 水平与阿尔茨海默病中异常的神经元可塑性标志物有关。
Mol Neurodegener. 2022 Mar 28;17(1):27. doi: 10.1186/s13024-022-00521-3.
3
Tau-related grey matter network breakdown across the Alzheimer's disease continuum.tau 相关灰质网络在阿尔茨海默病连续体中的崩溃。
Alzheimers Res Ther. 2021 Aug 13;13(1):138. doi: 10.1186/s13195-021-00876-7.
4
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort.在非痴呆人群中应用 ATN 分类方案:来自 EPAD 队列的研究结果。
Alzheimers Dement. 2021 Jul;17(7):1189-1204. doi: 10.1002/alz.12292. Epub 2021 Apr 3.
5
Grey matter network trajectories across the Alzheimer's disease continuum and relation to cognition.阿尔茨海默病连续病程中的灰质网络轨迹及其与认知的关系。
Brain Commun. 2020 Aug 20;2(2):fcaa177. doi: 10.1093/braincomms/fcaa177. eCollection 2020.
6
Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults.β-淀粉样蛋白和tau 对认知健康老年人皮质厚度的影响不同。
Alzheimers Dement. 2021 Jul;17(7):1085-1096. doi: 10.1002/alz.12249. Epub 2020 Dec 15.
7
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease.厘清阿尔茨海默病中淀粉样蛋白-β和 tau 与突触和轴突丢失的关联。
Brain. 2021 Feb 12;144(1):310-324. doi: 10.1093/brain/awaa395.
8
Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer's Disease.tau 与淀粉样蛋白与非典型阿尔茨海默病静息态功能连接的关系。
Cereb Cortex. 2021 Feb 5;31(3):1693-1706. doi: 10.1093/cercor/bhaa319.
9
Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's disease.单个体素灰质网络可预测临床前阿尔茨海默病患者的未来皮质萎缩。
Neurobiol Aging. 2020 Oct;94:71-80. doi: 10.1016/j.neurobiolaging.2020.05.008. Epub 2020 May 21.
10
ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies.ExploreASL:一个用于多中心 ASL 灌注 MRI 研究的图像处理流水线。
Neuroimage. 2020 Oct 1;219:117031. doi: 10.1016/j.neuroimage.2020.117031. Epub 2020 Jun 8.